52.54
price down icon9.21%   -5.33
after-market Dopo l'orario di chiusura: 53.53 0.99 +1.88%
loading

Perché le azioni Hims Hers Health Inc (HIMS) sono in ribasso?

Abbiamo notato un calo di 9.21% nelle azioni di Hims Hers Health Inc (HIMS) durante la sessione di negoziazione di 2025-10-03. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-08-08:

Shares of Hims & Hers Health (HIMS) dropped by 5.82% from $7.90 to $7.44 in the trading on Tuesday, August 8, 2023. The reason why HIMS is down today is due to a downgrade rating form Moody's after Q2 earnings report. In Q2 2023, the company saw a loss of three cents per share, surpassing the expected loss of six cents. Quarterly sales reached $207.91 million, exceeding the estimated $204.62 million and marking an 83.08% increase from the previous year's $113.56 million. Hims & Hers also reported a 74% year-over-year growth in subscribers. The company raised its full-year 2023 revenue guidance to a range of $830 million to $850 million and anticipates third-quarter revenue between $217 million and $222 million. Despite positive results, the analysts from Moody's downgraded on HIMS stock, as they claimed that there would be challenges for the company in the future.

drug_manufacturers_specialty_generic RDY
$14.16
price up icon 0.64%
$10.19
price up icon 0.79%
$20.64
price up icon 0.83%
$137.03
price up icon 0.21%
$453.07
price up icon 2.17%
Capitalizzazione:     |  Volume (24 ore):